A Phase II Study in Japan of the Safety And Antiviral Activity of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B With Incomplete Response to Current Lamivudine Therapy.
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 23 Feb 2010 Actual patient number (84) added as reported by ClinicalTrials.gov.
- 20 Jan 2010 New trial record